Male hypogonadism is a medical condition characterized erotic by insufficient production of testosterone by the testes. Because testosterone plays a critical role in male physiology, reduced levels of this hormone can affect numerous bodily functions.
Hypogonadism may be classified into two main categories: primary and secondary. Primary hypogonadism occurs when the testes themselves fail to produce adequate testosterone. This condition may result from genetic abnormalities, testicular injury, infection, or exposure to toxins.
Secondary hypogonadism originates from dysfunction in the hypothalamus or pituitary gland. When these structures fail to produce appropriate hormonal signals, the testes do not receive the stimulation necessary to generate testosterone.
Symptoms of hypogonadism vary depending on the age at which the condition develops. In adult men, common symptoms include decreased libido, erectile dysfunction, fatigue, loss of muscle mass, increased body fat, and mood disturbances.
Diagnosis involves measuring testosterone levels in the bloodstream, usually in the morning when hormone concentrations are highest. Additional laboratory tests may evaluate luteinizing hormone and follicle-stimulating hormone to determine whether the condition is primary or secondary.
Treatment strategies often involve testosterone replacement therapy. This therapy can be administered through injections, transdermal gels, patches, or subcutaneous implants.
While testosterone therapy can significantly improve symptoms, careful monitoring is necessary. Potential side effects include changes in blood cell counts, prostate enlargement, and alterations in cholesterol levels.
Comprehensive management of hypogonadism also includes addressing lifestyle factors such as obesity, stress, and physical inactivity, which may contribute to hormonal imbalance.